LF
REGN icon

Lansforsakringar Fondforvaltning’s Regeneron Pharmaceuticals REGN Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6M Sell
31,436
-1,665
-5% -$1.13M 0.09% 190
2026
Q1 		$25.6M Sell
33,101
-4,987
-13% -$3.82M 0.13% 136
2025
Q4 		$29.4M Sell
38,088
-237
-0.6% -$161K 0.15% 121
2025
Q3 		$21.5M Buy
38,325
+1,365
+4% +$772K 0.11% 152
2025
Q2 		$19.4M Sell
36,960
-2,922
-7% -$1.63M 0.11% 160
2025
Q1 		$25.3M Sell
39,882
-1,751
-4% -$1.2M 0.16% 122
2024
Q4 		$29.7M Buy
+41,633
New +$34.9M 0.17% 109

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lansforsakringar Fondforvaltning's REGN Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Regeneron Pharmaceuticals (REGN) stake by 5% in Q2 2026, selling an estimated $1.13M and leaving 31,436 shares worth $19.6M. The position accounts for 0.09% of the portfolio, ranked #190.

Lansforsakringar Fondforvaltning first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.7M in Q4 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 31,436 shares of Regeneron Pharmaceuticals worth $19.6M as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 1,665 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • Regeneron Pharmaceuticals made up 0.09% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #190 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Lansforsakringar Fondforvaltning's Regeneron Pharmaceuticals position peaked at $29.7M in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.